
New treatment for advanced breast cancer patients approved for NHS use
The National Institute for Health and Care Excellence (NICE) has approved the use of the tablet capivasertib, in combination with fulvestrant, for patients with hormone receptor-positive, HER2-negative breast cancer that has progressed after earlier …